SEBI Registration No - INA000003197 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS.



Generic medicines in India

The story of generic drugs versus branded drugs being used to treat patients all over the world is not new. While it is acceptable that good quality generics can be compared to the branded drugs, the quality depends upon the processing and manufacturing of a research molecule.
As per the rich experience of the doctors, the original molecules are more competent in curing the root of the disease as compared to the various molecules collected and collaborated to form medicines through dubious ways.
The drug control mechanisms in India have huge hurdles in terms of availability of manpower and technology. The other hurdles include non-availability of greater number of qualified pharmacists & dispensers on medical shops.
Regarding the drug pricing, the National Pharmaceutical Pricing Authority can always lessen the maximum retail price, and leave very little room for manipulation by the pharma companies.
Government may also consider introducing static code of marketing for curbing the cost of medicines.